Call Us – We’re Easy to Talk To
(214) 999-9999

Elder Law • Medicaid Planning • VA Benefits

Lilly Study Shows Antibody Treatment Prevents Infection in Nursing Homes

Mar 10, 2021

The AP reports that “Eli Lilly said Thursday its COVID-19 antibody drug can prevent illness in residents and staff of nursing homes and other long-term care locations” in “the first major study to show such a treatment may prevent disease.” In a study of over 1,000 participants, recipients of “the drug had up to a 57% lower risk of getting COVID-19 compared to others at the same facility who got a placebo, the drugmaker said,” with the risk “reduced by up to 80%” among residents only. Lilly “said it would publish results in a journal soon,” and, “said it will seek expansion” of its FDA emergency use authorization “to include using the drug to prevent and treat COVID-19 in long-term care facilities.”

The Wall Street Journal reports that Lilly Chief Scientific Officer Daniel Skovronsky said the antibody treatment, bamlanivimab, may be useful as a preventive measure before vaccines reach long-term care facilities, which account for a major percentage of COVID-related deaths. According to the CDC, about 1.9 million doses have been administered to nursing homes, which house approximately 3 million residents. The New York Times reports, “The data have not yet been peer-reviewed or published,” though “the company expects to present the findings at a future medical meeting and to publish them in a peer-reviewed journal.”

From the news release of the American Association for Justice.

Topics

Archives

elder law attorney, estate planning, asset protection, medicaid planning, va benefits

Since starting his practice of law in 1971 Mr. Kraft has helped many thousands of people address their concerns and achieve their goals. He is committed to giving seniors and the people who love them information to cope with living and aging.

Contact us to see how we can help!